Italian researchers at Ancona University Hospital documented a critical treatment pivot for a patient suffering from hypermobile Ehlers-Danlos syndrome. The 24-year-old woman faced severe gastrointestinal dysfunction and failed multiple central venous catheters due to abnormal tissue reactions.
Standard parenteral nutrition management triggered painful vascular complications, including fever and subcutaneous fibrinoid reactions. Medical teams determined the connective tissue disorder was causing the device failures.
The solution involved switching to post-pyloric enteral nutrition via a nasojejunal tube. This bypassed the dysfunctional stomach phase, stabilizing weight and reducing orthostatic symptoms.
The outcome marks a significant shift in managing complex metabolic disorders. Patients now have a less invasive pathway to restore intestinal function without compromising vascular integrity.